World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Checklist of Responsibilities for the Scientific Editor of This Article

Publishing Process of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4916)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

343

WORD

213

HTML

2255

Figures (1-6)

272

Tables (1-2)

164

Sum=3247

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

444

Download

1225

Sum=1669

May 27, 2021 (publication date) through Nov 30, 2023

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Maslennikov R, Ivashkin V, Efremova I, Alieva A, Kashuh E, Tsvetaeva E, Poluektova E, Shirokova E, Ivashkin K. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis. World J Hepatol 2021; 13(5): 557-570 [PMID: 34131470 DOI: 10.4254/wjh.v13.i5.557]
URL:	https://www.wjgnet.com/1948-5182/full/v13/i5/557.htm

Number	Citing Articles
1	Roman Maslennikov, Vladimir Ivashkin, Aliya Alieva, Elena Poluektova, Anna Kudryavtseva, George Krasnov, Maria Zharkova, Yuri Zharikov. Gut dysbiosis and body composition in cirrhosis. World Journal of Hepatology 2022; 14(6): 1210-1225 doi: 10.4254/wjh.v14.i6.1210 Abstract(351) \| Core Tip(204) \| Full Article(HTML)(1716) \| Full Article (PDF)-2692K(174) \| Full Article (Word)-459K(42) \| Audio-4696K(1) \| Peer-Review Report-182K(36) \| Answering Reviewers-87K(32) \| Times Cited (6) \| Total Visits (5064) \| Open
2	Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154 Abstract(369) \| Core Tip(371) \| Full Article(HTML)(3050) \| Full Article (PDF)-962K(468) \| Full Article (Word)-265K(146) \| Audio-2884K(0) \| Peer-Review Report-142K(90) \| Answering Reviewers-20K(97) \| Times Cited (17) \| Total Visits (6787) \| Open
3	Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?. World Journal of Clinical Cases 2021; 9(31): 9320-9332 doi: 10.12998/wjcc.v9.i31.9320 Abstract(274) \| Core Tip(229) \| Full Article(HTML)(1748) \| Full Article (PDF)-1232K(267) \| Full Article (Word)-194K(121) \| Audio-2527K(1) \| Peer-Review Report-179K(100) \| Answering Reviewers-78K(86) \| Times Cited (14) \| Total Visits (4564) \| Open
4	Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236 Abstract(197) \| Core Tip(186) \| Full Article(HTML)(1207) \| Full Article with Cover (PDF)-2077K(30) \| Full Article (Word)-351K(37) \| Audio-395K(5) \| Peer-Review Report-291K(13) \| Answering Reviewers-97K(21) \| Full Article (PDF)-967K(204) \| Full Article (XML)-396K(27) \| Times Cited (0) \| Total Visits (2704) \| Open
5	Kazuki Natsui, Atsunori Tsuchiya, Risa Imamiya, Mayuko Osada‐Oka, Yui Ishii, Yohei Koseki, Nobutaka Takeda, Kei Tomiyoshi, Fusako Yamazaki, Yuki Yoshida, Riuko Ohashi, Yiwei Ling, Koji Ueda, Nobuko Moritoki, Kazuhiro Sato, Takahiro Nakajima, Yoshinori Hasegawa, Shujiro Okuda, Shinsuke Shibata, Shuji Terai. Escherichia coli‐derived outer‐membrane vesicles induce immune activation and progression of cirrhosis in mice and humans. Liver International 2023; 43(5): 1126 doi: 10.1111/liv.15539
6	Kathrin Rothe, Tobias Bachfischer, Siranush Karapetyan, Alexander Hapfelmeier, Milena Wurst, Sabine Gleich, Karl Dichtl, Roland M. Schmid, Julian Triebelhorn, Laura Wagner, Johanna Erber, Florian Voit, Rainer Burgkart, Andreas Obermeier, Ulrich Seibold, Dirk H. Busch, Patrick C. Rämer, Christoph D. Spinner, Jochen Schneider, Florence Claude Doucet-Populaire. Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci cohort. Microbiology Spectrum 2023; doi: 10.1128/spectrum.02585-23
7	Yushan Bu, Yisuo Liu, Tai Zhang, Yinxue Liu, Zhe Zhang, Huaxi Yi. Bacteriocin-Producing Lactiplantibacillus plantarum YRL45 Enhances Intestinal Immunity and Regulates Gut Microbiota in Mice. Nutrients 2023; 15(15): 3437 doi: 10.3390/nu15153437
8	Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis. World Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525 Abstract(234) \| Core Tip(205) \| Full Article(HTML)(703) \| Full Article with Cover (PDF)-1866K(75) \| Full Article (Word)-239K(34) \| Audio-1509K(2) \| Peer-Review Report-221K(16) \| Answering Reviewers-113K(21) \| Full Article (PDF)-590K(32) \| Times Cited (0) \| Total Visits (1831) \| Open
9	Zengrong Wu, Hejun Zhou, Deliang Liu, Feihong Deng. Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1218552
10	Masahide Enomoto, Hiroaki Takaya, Tadashi Namisaki, Yukihisa Fujinaga, Norihisa Nishimura, Yasuhiko Sawada, Kosuke Kaji, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Takashi Inoue, Masanori Matsumoto, Hitoshi Yoshiji. Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis. Hepatology Research 2022; 52(4): 390 doi: 10.1111/hepr.13743
11	Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial. World Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667 Abstract(213) \| Core Tip(329) \| Full Article(HTML)(1258) \| Full Article (PDF)-1849K(150) \| Full Article (Word)-226K(62) \| Audio-2401K(0) \| Peer-Review Report-244K(37) \| Answering Reviewers-72K(31) \| Times Cited (4) \| Total Visits (3956) \| Open
12	D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential. Dokazatel'naya gastroenterologiya 2022; 11(4): 65 doi: 10.17116/dokgastro20221104165
13	Ridda Manzoor, Weshah Ahmed, Nariman Afify, Mashal Memon, Maryam Yasin, Hamda Memon, Mohammad Rustom, Mohannad Al Akeel, Noora Alhajri. Trust Your Gut: The Association of Gut Microbiota and Liver Disease. Microorganisms 2022; 10(5): 1045 doi: 10.3390/microorganisms10051045
14	Vladimir Ivashkin, Oleg Shifrin, Roman Maslennikov, Elena Poluektova, Alexander Korolev, Anna Kudryavtseva, George Krasnov, Nona Benuni, Giovanni Barbara. Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02690-x
15	Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Anna Kudryavtseva, George Krasnov. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World Journal of Gastroenterology 2022; 28(10): 1067-1077 doi: 10.3748/wjg.v28.i10.1067 Abstract(350) \| Core Tip(366) \| Full Article(HTML)(1999) \| Full Article (PDF)-2025K(252) \| Full Article (Word)-316K(113) \| Audio-1916K(8) \| Peer-Review Report-256K(80) \| Answering Reviewers-230K(100) \| Times Cited (11) \| Total Visits (6437) \| Open
16	Irina Efremova, Roman Maslennikov, Elena Poluektova, Maria Zharkova, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Elena Shirokova, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis. Microorganisms 2023; 11(9): 2202 doi: 10.3390/microorganisms11092202
17	Roman Maslennikov, Elena Poluektova, Oxana Zolnikova, Alla Sedova, Anastasia Kurbatova, Yulia Shulpekova, Natyia Dzhakhaya, Svetlana Kardasheva, Maria Nadinskaia, Elena Bueverova, Vladimir Nechaev, Anna Karchevskaya, Vladimir Ivashkin. Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis. International Journal of Molecular Sciences 2023; 24(22): 16502 doi: 10.3390/ijms242216502
18	Xinlu Cao, Oksana Zolnikova, Roman Maslennikov, Maria Reshetova, Elena Poluektova, Arina Bogacheva, Maria Zharkova, Vladimir Ivashkin. Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis. Metabolites 2023; 13(7): 859 doi: 10.3390/metabo13070859
19	Jian Wu, Mariza Bortolanza, Guanghua Zhai, Anquan Shang, Zongxin Ling, Bin Jiang, Xiaochen Shen, Yiwen Yao, Jiong Yu, Lanjuan Li, Hongcui Cao. Gut microbiota dysbiosis associated with plasma levels of Interferon‐γ and viral load in patients with acute hepatitis E infection. Journal of Medical Virology 2022; 94(2): 692 doi: 10.1002/jmv.27356